Story Navigation
-
DiscoveryNovartis Institutes for BioMedical ResearchRare DiseasesReimagine MedicineTargeted TherapyClinical ResearchClinical TrialsGenetic Disease
Rare speed on a rare disease
An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.
Discovery -
From Our LabsDrug DiscoveryNovartis Institutes for BioMedical ResearchNew Scientific DiscoveriesClinical ResearchBiomedical Science
How to address the culture gap between academia and industry in biomedicine
Experts call for significant changes to facilitate the discovery of new treatments.
From Our Labs -
Access to HealthcareAccess to HealthcareCancerChronic IllnessLiving With DiseaseNovartis AccessNovartis Social Business
Bringing modern medicine to rural Vietnam
Efforts are underway to reinforce health education and healthcare delivery in rural Vietnam to combat a rise in chronic diseases such as diabetes, hypertension and respiratory ailments.
Access to Healthcare -
From Our LabsGene SequencingNext Generation ScientistNovartis Institutes for BioMedical ResearchNext Generation SequencingScientific Discoveries
Giraffes have high blood pressure. Why don’t they drop dead?
A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.
From Our Labs -
DiscoveryBiomedical ResearchDiseasesMedical InnovationsClinical TrialsDiabetes
Stepping toward regenerative medicine for diabetes
Discovery points toward treatment options beyond insulin injections
Discovery -
DiscoveryBiomedical ResearchMedical InnovationsNovartis Institutes for BioMedical ResearchScientific DiscoveriesDiabetes
Compounds spur insulin-producing cells to replicate in the lab
Discovery -
DiscoveryNovartis Institutes for BioMedical ResearchReimagine MedicineScientific ResearchClinical ResearchClinical TrialsGene Testing
Clinical trials make a move toward mice
By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs
Discovery -
Access to HealthcareAccess to HealthcareChronic IllnessFuture of HealthcareNovartis AccessNovartis Social Business
Delivering access: first launch in Kenya
Chronic diseases kill 38 million people per year worldwide; almost three-quarters of those deaths occur in low- and middle-income countries. It’s time to act.
Access to Healthcare -
DiscoveryBiomedical ResearchDrug DiscoveryNovartis Institutes for BioMedical ResearchClinical TrialsAlzheimer’s diseaseDrug Development
Getting down to the roots of Alzheimer’s disease
Experimental treatments for Alzheimer’s disease put the amyloid cascade hypothesis to the test.
Discovery -
DiscoveryBiomedical ResearchDiseasesMedical InnovationsClinical Trials
Stopping Alzheimer's disease before it starts
Novartis collaborates with the Banner Alzheimer’s Institute to test treatments for preventing Alzheimer’s disease.
Discovery -
Patient PerspectivesAccess to HealthcareChronic IllnessDiseasesLiving With Disease
Debunking the myths about multiple sclerosis
We surveyed 7,000 people in seven countries to find out what they know about multiple sclerosis (MS). Our survey identified several surprising misconceptions.
Patient Perspectives -
DiscoveryNovartis Institutes for BioMedical ResearchReimagine MedicineNext Generation SequencingTargeted TherapyClinical TrialsCancer Research Institute
Novartis cancer researchers advance precision medicine
Learn how NIBR uses next generation sequencing to transform clinical trials and diagnostics in oncology.
Discovery
Pagination
- ‹ Previous page
- 1
- …
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- …
- 32
- › Next page